102
Views
0
CrossRef citations to date
0
Altmetric
Perspective

Patient-centered care in von Willebrand disease: are we there yet?

, , , , &
Pages 641-649 | Received 14 Apr 2023, Accepted 28 Jul 2023, Published online: 15 Aug 2023

References

  • VanderMeulen H, Arya S, Nersesian S, et al. What have we learned about the patient’s experience of von Willebrand disease? A focus on women. Hematology. 2022;2022(1):631–636. doi: 10.1182/hematology.2022000391
  • Lillicrap D. von Willebrand disease: advances in pathogenetic understanding, diagnosis, and therapy. Hematology Am Soc Hematol Educ Program. 2013;2013(1):254–260. doi: 10.1182/asheducation-2013.1.254
  • Corrales-Medina FF, Federici AB, Srivastava A, et al. A need to increase von Willebrand disease awareness: vwdtest.com – a global initiative to help address this gap. Blood Rev. 2022;101018:101018. doi: 10.1016/j.blre.2022.101018
  • Eladly F, Miesbach W. Von Willebrand disease—specific aspects in women. Hamostaseologie. 2022;42(5):330–336. doi: 10.1055/a-1891-9976
  • Sabih A, Babiker HM Von Willebrand Disease. StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2022 [cited 2023 Mar 15]. Available from: http://www.ncbi.nlm.nih.gov/books/NBK459222/.
  • Mannucci PM, Wood AJJ. Treatment of von Willebrand’s disease. N Engl J Med. 2004;351(7):683–694. doi: 10.1056/NEJMra040403
  • Saenko EL, Ananyeva NM, Tuddenham EGD, et al. Factor VIII - novel insights into form and function. Br J Haematol. 2002;119(2):323–331. doi: 10.1046/j.1365-2141.2002.03793.x
  • Smith NL, Chen M-H, Dehghan A, et al. Novel associations of multiple genetic loci with plasma levels of factor VII, factor viii, and von Willebrand factor. Circulation. 2010;121(12):1382–1392. doi: 10.1161/CIRCULATIONAHA.109.869156
  • James PD, Goodeve AC. von Willebrand Disease. Genet Med. 2011;13:365–376. doi: 10.1097/GIM.0b013e3182035931
  • Goodeve AC. The genetic basis of von Willebrand disease. Blood Rev. 2010;24(3):123–134. doi: 10.1016/j.blre.2010.03.003
  • Flood VH, Garcia J, Haberichter SL. The role of genetics in the pathogenesis and diagnosis of type 1 Von Willebrand disease. Current Opinion Hematol. 2019;26(5):331. doi: 10.1097/MOH.0000000000000524
  • Sabater-Lleal M, Huffman JE, de Vries PS, et al. Genome-Wide Association Transethnic Meta-Analyses Identifies Novel Associations Regulating Coagulation Factor VIII and von Willebrand Factor Plasma Levels. Circulation. 2019;139(5):620–635. doi: 10.1161/CIRCULATIONAHA.118.034532
  • James PD, Connell NT, Ameer B, et al. ASH ISTH NHF WFH 2021 guidelines on the diagnosis of von Willebrand disease. Blood Adv. 2021;5(1):280–300. doi: 10.1182/bloodadvances.2020003265
  • Kujovich JL. von Willebrand’s disease and menorrhagia: prevalence, diagnosis, and management. Am J Hematol. 2005;79(3):220–228. doi: 10.1002/ajh.20372
  • James AH, Eikenboom J, Federici AB. State of the art: von Willebrand disease. Haemophilia. 2016;22(5):54–59. doi: 10.1111/hae.12984
  • Berntorp E, Abshire T. vWD PN Steering Committee. The von Willebrand disease prophylaxis network (vWD PN): exploring a treatment concept. Thromb Res. 2006;118 Suppl 1:S19–22. doi: 10.1016/j.thromres.2006.01.016
  • Abshire T, Cox-Gill J, Kempton CL, et al. Prophylaxis escalation in severe von Willebrand disease: a prospective study from the von Willebrand Disease Prophylaxis Network. J Thromb Haemost. 2015;13(9):1585–1589. doi: 10.1111/jth.12995
  • Connell NT, Flood VH, Brignardello-Petersen R, et al. ASH ISTH NHF WFH 2021 guidelines on the management of von Willebrand disease. Blood Adv. 2021;5:301–325. doi: 10.1182/bloodadvances.2020003264
  • Arya S, Wilton P, Page D, et al. “They Don’t Really Take My Bleeds Seriously”: Barriers to Care for Women with Inherited Bleeding Disorders. Journal Of Thrombosis And Haemostasis [Internet]. [cited 2021 Apr 1];n/a. Available from: https://pericles.pericles-prod.literatumonline.com/doi/abs/10.1111/jth.15311.
  • Sadler JE, Mannucci PM, Berntorp E, et al. Impact, diagnosis and treatment of von Willebrand disease. Thromb Haemost. 2000;84(8):160–174. doi: 10.1055/s-0037-1613992
  • Silwer J. von Willebrand’s disease in Sweden. Acta Paediatr Scand Suppl. 1973;238:1–159.
  • Miller CH, Graham JB, Goldin LR, et al. Genetics of classic von Willebrand’s disease. I. Phenotypic variation within families. Blood. 1979;54(1):117–136. doi: 10.1182/blood.V54.1.117.117
  • Kessler CM, Friedman K, Schwartz BA, et al. The pharmacokinetic diversity of two von Willebrand factor (VWF)/factor VIII (FVIII) concentrates in subjects with congenital von Willebrand disease. Results from a prospective, randomised crossover study. Thromb Haemost. 2011;106:279–288. doi: 10.1160/TH11-02-0057
  • Kadir RA, Economides DL, Sabin CA, et al. Assessment of menstrual blood loss and gynaecological problems in patients with inherited bleeding disorders. Haemophilia. 1999;5:40–48. doi: 10.1046/j.1365-2516.1999.00285.x
  • Kouides PA, Phatak PD, Burkart P, et al. Gynaecological and obstetrical morbidity in women with type I von Willebrand disease: results of a patient survey. Haemophilia. 2000;6(6):643–648. doi: 10.1046/j.1365-2516.2000.00447.x
  • Kirtava A, Crudder S, Dilley A, et al. Trends in clinical management of women with von Willebrand disease: a survey of 75 women enrolled in haemophilia treatment centres in the United States. Haemophilia. 2004;10(2):158–161. doi: 10.1046/j.1351-8216.2003.00832.x
  • Kirtava A, Drews C, Lally C, et al. Medical, reproductive and psychosocial experiences of women diagnosed with von Willebrand’s disease receiving care in haemophilia treatment centres: a case-control study. Haemophilia. 2003;9(3):292–297. doi: 10.1046/j.1365-2516.2003.00756.x
  • Ragni MV, Bontempo FA, Hassett AC. von Willebrand disease and bleeding in women. Haemophilia. 1999;5:313–317. doi: 10.1046/j.1365-2516.1999.00342.x
  • Payandeh M, Rahimi Z, Kansestani AN, et al. Clinical features and types of von Willebrand disease in women with menorrhagia referred to hematology clinic of kermanshah. Int J Hematol Oncol Stem Cell Res. 2013;7(2):1–5. doi: 10.1111/hae.12012.c
  • Connell NT, James PD, Brignardello-Petersen R, et al. von Willebrand disease: proposing definitions for future research. Blood Adv. 2021;5(2):565–569. doi: 10.1182/bloodadvances.2020003620
  • Gokyildiz S, Aslan E, Beji NK, et al. The Effects of Menorrhagia on Women’s Quality of Life: A Case-Control Study. ISRN Obstet Gynecol. 2013;2013:e918179. doi: 10.1155/2013/918179
  • De Wee EM, Mauser-Bunschoten EP, Van Der Bom JG, et al. Health-related quality of life among adult patients with moderate and severe von Willebrand disease. J Thromb Haemost. 2010;8:1492–1499. doi: 10.1111/j.1538-7836.2010.03864.x
  • Barr RD, Sek J, Horsman J, et al. Health status and health-related quality of life associated with von Willebrand disease. Am J Hematol. 2003;73(2):108–114. doi: 10.1002/ajh.10327
  • Roberts JC, Kulkarni R, Kouides PA, et al. Healthcare Utilization and Health Related Quality of Life in Persons with Von Willebrand Disease. Blood. 2020;136(Supplement 1):3–4. 10.1182/blood-2020-143055
  • Santana MJ, Manalili K, Jolley RJ, et al. How to practice person‐centred care: A conceptual framework. Health Expect. 2018;21(2):429–440. doi: 10.1111/hex.12640
  • America I of M (US) C on Q of HC in. A New Health System for the 21st Century [Internet]. Crossing the Quality Chasm: A New Health System for the 21st Century. National Academies Press (US); 2001 [cited 2023 Mar 15]. Available from: https://www.ncbi.nlm.nih.gov/books/NBK222273/.
  • Vrijhoef HJ. Putting patients at the centre of health care. Int J Care Coord. 2021;24(2):37–38. doi: 10.1177/20534345211019964
  • Michael Soucie J, Miller CH, Byams VR, et al. Occurrence rates of von Willebrand disease among people receiving care in specialized treatment centres in the United States. Haemophilia. 2021;27(3):445–453. doi: 10.1111/hae.14263
  • Werner EJ, Broxson EH, Tucker EL, et al. Prevalence of von Willebrand disease in children: A multiethnic study. J Paediatr. 1993;123(6):893–898. doi: 10.1016/S0022-3476(05)80384-1
  • Rodeghiero F, Castaman G, Dini E. Epidemiological Investigation of the Prevalence of von Willebrand’s Disease. Blood. 1987;69(2):454–459. doi: 10.1182/blood.V69.2.454.454
  • Goodeve A, James P. von Willebrand Disease. In: Adam M, Mirzaa G Pagon R, Eds. GeneReviews® [Internet]. Seattle (WA): University of Washington; 1993 [cited 2023 Jul 5]. http://www.ncbi.nlm.nih.gov/books/NBK7014/
  • Atiq F, Saes JL, Punt MC, et al. Major differences in clinical presentation, diagnosis and management of men and women with autosomal inherited bleeding disorders. EClinicalMedicine. 2021;32:100726. doi: 10.1016/j.eclinm.2021.100726
  • Sanigorska A, Chaplin S, Holland M, et al. The lived experience of women with a bleeding disorder: A systematic review. Res Pract Thromb Haemost. 2022;6(1):e12652. doi: 10.1002/rth2.12652
  • Ragni MV, Machin N, Malec LM, et al. Von Willebrand Factor for Menorrhagia: A Survey and Literature Review. Haemophilia. 2016;22(3):397–402. doi: 10.1111/hae.12898
  • Arya S, Wilton P, Page D, et al. Healthcare provider perspectives on inequities in access to care for patients with inherited bleeding disorders. PLoS One. 2020;15(2):e0229099. doi: 10.1371/journal.pone.0229099
  • Khalife R, Tinmouth A, Duffett L, et al. Knowledge gaps in bleeding disorders: Results from an objective structured oral examination in internal medicine residency training. J Thromb Haemost. 2022;20(6):1325–1330. doi: 10.1111/jth.15693
  • Sidonio RF, Haley KM, Fallaize D. Impact of diagnosis of von Willebrand disease on patient outcomes: Analysis of medical insurance claims data. Haemophilia. 2017;23(5):743–749. doi: 10.1111/hae.13292
  • Deforest M, Grabell J, Albert S, et al. Generation and optimization of the self-administered bleeding assessment tool and its validation as a screening test for von Willebrand disease. Haemophilia. 2015;21:e384–388. doi: 10.1111/hae.12747
  • Rodeghiero F, Tosetto A, Abshire T, et al. ISTH/SSC bleeding assessment tool: a standardized questionnaire and a proposal for a new bleeding score for inherited bleeding disorders. J Thromb Haemost. 2010;8(9):2063–2065. 10.1111/j.1538-7836.2010.03975.x
  • Tosetto A, Castaman G, Plug I, et al. Prospective evaluation of the clinical utility of quantitative bleeding severity assessment in patients referred for hemostatic evaluation. J Thromb Haemost. 2011;9(6):1143–1148. doi: 10.1111/j.1538-7836.2011.04265.x
  • Bowman M, Tuttle A, Notley C, et al. The Genetics of Canadian Type 3 von Willebrand Disease (VWD): Further Evidence for Co-dominant Inheritance of Mutant Alleles. J Thromb Haemost. 2013;11:512–520. doi: 10.1111/jth.12130
  • Arya S, Wilton P, Page D, et al. “Everything was blood when it comes to me”: Understanding the lived experiences of women with inherited bleeding disorders. J Thromb Haemost. 2020;18(12):3211–3221. doi: 10.1111/jth.15102
  • Witkop M, Guelcher C, Forsyth A, et al. Treatment outcomes, quality of life, and impact of hemophilia on young adults (aged 18-30 years) with hemophilia. Am J Hematol. 2015;90(2):S3–10. doi: 10.1002/ajh.24220
  • Ambroggi M, Biasini C, Fornari F, et al. Distance as a barrier to cancer diagnosis and treatment: review of the literature. Ann Oncol. 2015;26:vi126. doi: 10.1093/annonc/mdv347.12
  • Xu Y, Deforest M, Grabell J, et al. Relative contributions of bleeding scores and iron status on health-related quality of life in von Willebrand disease: a cross-sectional study. Haemophilia. 2017;23(1):115–121. doi: 10.1111/hae.13062
  • Limperg PF, Joosten MMH, Fijnvandraat K, et al. Male gender, school attendance and sports participation are positively associated with health-related quality of life in children and adolescents with congenital bleeding disorders. Haemophilia. 2018;24(3):395–404. doi: 10.1111/hae.13420
  • Castaman G, Katsarou O, Jansen N, et al. Clinical, economic, and health-related quality of life burden associated with von Willebrand disease in adults and children: Systematic and targeted literature reviews. Haemophilia. 2023;29(2):411–422. doi: 10.1111/hae.14655
  • WISH-QoL Study: Assessment of Health-Related Quality of Life and Health-Economic Aspects in Patients with von Willebrand Disease in France: Results from the 2nd Interim Analysis on the 355 Enrolled Patients [Internet]. ISTH Congress Abstracts. [cited 2023 Mar 18]. Available from: https://abstracts.isth.org/abstract/wish-qol-study-assessment-of-health-related-quality-of-life-and-health-economic-aspects-in-patients-with-von-willebrand-disease-in-france-results-from-the-2nd-interim-analysis-on-the-355-enrolled-pa/.
  • Kalot MA, Al-Khatib M, Connell NT, et al. An international survey to inform priorities for new guidelines on von Willebrand disease. Haemophilia. 2020;26(1):106–116. doi: 10.1111/hae.13881
  • Laffan MA, Lester W, O’Donnell JS, et al. The diagnosis and management of von Willebrand disease: a United Kingdom Haemophilia Centre Doctors Organization guideline approved by the British Committee for Standards in Haematology. Br J Haematol. 2014;167(4):453–465. doi: 10.1111/bjh.13064
  • Nichols WL, Hultin MB, James AH, et al. von Willebrand disease (VWD): evidence-based diagnosis and management guidelines, the National Heart, Lung, and Blood Institute (NHLBI) Expert Panel report (USA). Haemophilia. 2008;14(2):171–232. doi: 10.1111/j.1365-2516.2007.01643.x
  • Wang M, Konkle BA, Sidonio RF Jr, et al. von Willebrand disease Outreach into Integrated Care Education (VOICE): a call to action. Haemophilia. 2017;23(4):e370–e373. doi: 10.1111/hae.13258
  • Seaman CD, Bertolet M, Zhang J, et al. Quality of periprocedural care in patients with von Willebrand disease. Haemophilia. 2021;27(5):830–836. doi: 10.1111/hae.14389
  • Treatment of Heavy Menstrual Bleeding in a Multidisciplinary Young Women’s Bleeding Clinic for Adolescents: An Institutional 2-year Experience [Internet]. ISTH Congress Abstracts. [cited 2023 Mar 19]. Available from: https://abstracts.isth.org/abstract/treatment-of-heavy-menstrual-bleeding-in-a-multidisciplinary-young-womens-bleeding-clinic-for-adolescents-an-institutional-2-year-experience/.
  • Zia A, Lau M, Journeycake J, et al. Developing a multidisciplinary Young Women’s Blood Disorders Program: a single-centre approach with guidance for other centres. Haemophilia. 2016;22(2):199–207. doi: 10.1111/hae.12836
  • VanderMeulen H, Petrucci J, Floros G, et al. The experience of postpartum bleeding in women with inherited bleeding disorders. Res Pract Thromb Haemost. 2019;3(4):733–740. doi: 10.1002/rth2.12246
  • Turan O, Kadir RA. Pregnancy in special populations: challenges and solutions practical aspects of managing von Willebrand disease in pregnancy. Hematology Am Soc Hematol Educ Program. 2021;2021(1):552–558. doi: 10.1182/hematology.2021000321
  • Leebeek FWG, Duvekot J, Kruip MJHA. How I manage pregnancy in carriers of hemophilia and patients with von Willebrand disease. Blood. 2020;136(19):2143–2150. doi: 10.1182/blood.2019000964
  • Rathert C, Wyrwich MD, Boren SA. Patient-centered care and outcomes: a systematic review of the literature. Med Care Res Rev. 2013;70(4):351–379. doi: 10.1177/1077558712465774
  • Bień-Barkowska K, Doroszkiewicz H, Bień B. Silent strain of caregiving: exploring the best predictors of distress in family carers of geriatric patients. Clin Interv Aging. 2017;12:263–274. doi: 10.2147/CIA.S125664
  • von Mackensen S, Myrin Westesson L, Kavakli K, et al. The impact of psychosocial determinants on caregivers’ burden of children with haemophilia (results of the BBC study). Haemophilia. 2019;25(3):424–432. doi: 10.1111/hae.13684
  • Khair K, Pelentsov L. Assessing the supportive care needs of parents with a child with a bleeding disorder using the Parental Needs Scale for Rare Diseases (PNS-RD): A single-centre pilot study. Haemophilia. 2019;25(5):831–837. doi: 10.1111/hae.13826
  • Myrin-Westesson L, Baghaei F, Friberg F. The experience of being a female carrier of haemophilia and the mother of a haemophilic child. Haemophilia. 2013;19(2):219–224. doi: 10.1111/hae.12026
  • Olsson A, Petrini P, Engman Grahn E, et al. HRQoL and psychosocial aspects of burden on caregivers to children with moderate or severe von Willebrand disease. Haemophilia. 2023;29(4):1056–1062. doi: 10.1111/hae.14811
  • Let’s talk period [Internet]. [cited 2021 Sep 10]. Available from: https://letstalkperiod.ca/.
  • Better You Know [Internet]. Better You Know. [cited 2023 Jul 5]. Available from: https://www.betteryouknow.org/node.
  • Home [Internet]. Know Your Flow. [cited 2023 Jul 5]. Available from: https://www.knowyourflow.ie/.
  • Home vwdtest [Internet]. vwdtest. [cited 2023 Jul 5]. Available from: https://vwdtest.com/.
  • James PD. Women and bleeding disorders: diagnostic challenges. Hematology Am Soc Hematol Educ Program. 2020;2020(1):547–552. doi: 10.1182/hematology.2020000140
  • Overview [Internet]. National Hemophilia Foundation. [cited 2023 Mar 20]. Available from: https://www.hemophilia.org/bleeding-disorders-a-z/overview.
  • Foundation for Women & Girls With Blood Disorders | Home [Internet]. [cited 2021 Sep 10]. Available from: https://www.fwgbd.org/.
  • Living with Von Willebrand’s Disease Patients Support Community – Support Group for people affected with Von Willebrand’s Disease [Internet]. [cited 2023 Jul 5]. Available from: https://www.livingwithvwd.org/.
  • Favaloro EJ. Von Willebrand disease: local diagnosis and management of a globally distributed bleeding disorder. Semin Thromb Hemost. 2011;37(5):440–455. doi: 10.1055/s-0031-1281028
  • Srivastava A. von Willebrand disease in the developing world. Semin Hematol. 2005;42(1):36–41. doi: 10.1053/j.seminhematol.2004.09.007
  • Montgomery RR, Flood VH. What have we learned from large population studies of von Willebrand disease? Hematology. 2016;2016(1):670–677. doi: 10.1182/asheducation-2016.1.670
  • Sukhu K, Poovalingam V, Mahomed R, et al. Ethnic variation in von Willebrand factor levels can influence the diagnosis of von Willebrand disease. Clin Lab Haematol. 2003;25(4):247–249. doi: 10.1046/j.1365-2257.2003.00523.x
  • Miesbach W, Berntorp E. Translating the success of prophylaxis in haemophilia to von Willebrand disease. Thromb Res. 2021;199:67–74. doi: 10.1016/j.thromres.2020.12.030
  • Weyand AC, James PD. Sexism in the management of bleeding disorders. Res Pract Thromb Haemost. 2021;5(1):51–54. doi: 10.1002/rth2.12468
  • Denis CV, Susen S, Lenting PJ. von Willebrand disease: what does the future hold? Blood. 2021;137(17):2299–2306. doi: 10.1182/blood.2020008501

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.